EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Asymptomatic spinal lesions in patients with AQP4‐IgG ‐positive NMOSD : A real‐world cohort study

Shugang Cao iD, Yunfei Zhu, Xiaosan Wu, Jing Du, Si Xu, Ping Cui, Qi Li iD, Mingwu Xia, Qun Xue, Yanghua Tian iD

Annals of Clinical and Translational Neurology · 2024-04 · 11 (4) · 905-915

DOI: 10.1002/acn3.52007 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 04.02.2024. Verfasst von Shugang Cao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China. Hauptthemen laut MEDLINE: Neuromyelitis Optica. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Plan of Jiangsu Province, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to explore the frequency and influencing factors of asymptomatic spinal lesions (ASLs) and their impact on subsequent relapses in patients with AQP4‐IgG‐positive NMOSD (AQP4‐NMOSD) in a real‐world setting.

Methods

We retrospectively reviewed clinical information and spinal MRI data from AQP4‐NMOSD patients who had at least one spinal cord MRI during their follow‐ups. Kaplan–Meier curves and Cox proportional hazards models were employed to ascertain potential predictors of remission ASLs and to investigate factors associated with subsequent relapses.

Results

In this study, we included 129 patients with AQP4‐NMOSD and reviewed 173 spinal MRIs during attacks and 89 spinal MRIs during remission. Among these, 6 ASLs (3.5%) were identified during acute attacks, while 8 ASLs (9%) were found during remission. Remission ASLs were linked to the use of immunosuppressive agents, particularly conventional ones, whereas no patients using rituximab developed ASLs ( p = 0.005). Kaplan–Meier curve analysis indicated that patients with ASLs had a significantly higher relapse risk (HR = 4.658, 95% CI: 1.519–14.285, p = 0.007) compared to those without. Additionally, the use of mycophenolate mofetil (HR = 0.027, 95% CI: 0.003–0.260, p = 0.002) and rituximab (HR = 0.035, 95% CI: 0.006–0.203, p < 0.001) significantly reduced the relapse risk. However, after accounting for other factors, the presence of ASLs did not exhibit a significant impact on subsequent relapses (HR = 2.297, 95% CI: 0.652–8.085, p = 0.195).

Interpretation

ASLs may be observed in patients with AQP4‐NMOSD. The presence of ASLs may signify an underlying inflammatory activity due to insufficient immunotherapy. The administration of immunosuppressive agents plays a key role in the presence of remission ASLs and the likelihood of subsequent relapses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuromyelitis OpticaHumansCohort StudiesAquaporin 4RituximabRetrospective StudiesImmunosuppressive AgentsRecurrenceImmunoglobulin G

Substanzen

Aquaporin 4RituximabImmunosuppressive AgentsImmunoglobulin G

Autor:innen und Institutionen

  • Department of Neurology, Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
  • Department of Neurology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, China.
  • Department of Neurology, First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Department of Radiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230011, China.

ORCID-Profile: Shugang Cao, Qi Li, Yanghua Tian

Förderung

  • Key Research and Development Plan of Jiangsu Province
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Cao, S., Zhu, Y., Wu, X., Du, J., Xu, S., Cui, P., Li, Q., Xia, M., Xue, Q., & Tian, Y. (2024). Asymptomatic spinal lesions in patients with AQP4‐IgG ‐positive NMOSD : A real‐world cohort study. Annals of Clinical and Translational Neurology, 11(4), 905-915. https://doi.org/10.1002/acn3.52007

Vancouver

Cao S, Zhu Y, Wu X, Du J, Xu S, Cui P, et al. Asymptomatic spinal lesions in patients with AQP4‐IgG ‐positive NMOSD : A real‐world cohort study. Annals of Clinical and Translational Neurology. 2024;11(4):905-915. doi:10.1002/acn3.52007

BibTeX
@article{Cao2024,
  author = {Cao, Shugang and Zhu, Yunfei and Wu, Xiaosan and Du, Jing and Xu, Si and Cui, Ping and Li, Qi and Xia, Mingwu and Xue, Qun and Tian, Yanghua},
  title = {Asymptomatic spinal lesions in patients with AQP4‐IgG ‐positive NMOSD : A real‐world cohort study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  volume = {11},
  number = {4},
  pages = {905--915},
  doi = {10.1002/acn3.52007}
}
Kostenlos starten →